Endymed Ltd (ENDY.TA)
ILA 320.1
(0.0%)
ILA 320.1
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 22.77 Million USD | 6.77% |
| 2022 | 21.33 Million USD | -2.06% |
| 2021 | 21.78 Million USD | 51.85% |
| 2020 | 14.34 Million USD | -12.78% |
| 2019 | 16.44 Million USD | -10.88% |
| 2018 | 18.45 Million ILS | 5.2% |
| 2017 | 17.54 Million ILS | 23.08% |
| 2016 | 14.25 Million ILS | 10.05% |
| 2015 | 12.95 Million USD | 22.8% |
| 2014 | 10.54 Million USD | 79.94% |
| 2013 | 5.86 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 4.76 Million USD | 11.46% |
| 2024 Q1 | 4.27 Million USD | -21.66% |
| 2023 Q2 | 5.45 Million USD | -19.25% |
| 2023 Q1 | 6.75 Million USD | 22.82% |
| 2023 Q4 | 5.45 Million USD | 6.94% |
| 2023 Q3 | 5.1 Million USD | -6.49% |
| 2023 FY | 22.77 Million USD | 6.77% |
| 2022 Q3 | 4.23 Million USD | -17.16% |
| 2022 FY | 21.33 Million USD | -2.06% |
| 2022 Q4 | 5.5 Million USD | 29.97% |
| 2022 Q2 | 5.11 Million USD | -21.2% |
| 2022 Q1 | 6.48 Million USD | 12.78% |
| 2021 Q4 | 5.75 Million USD | 4.81% |
| 2021 Q1 | 4.49 Million USD | 8.19% |
| 2021 Q2 | 6.04 Million USD | 34.39% |
| 2021 FY | 21.78 Million USD | 51.85% |
| 2021 Q3 | 5.48 Million USD | -9.25% |
| 2020 Q3 | 4.15 Million USD | 37.97% |
| 2020 Q1 | 3.01 Million USD | -20.52% |
| 2020 Q2 | 3.01 Million USD | 0.0% |
| 2020 Q4 | 4.15 Million USD | 0.0% |
| 2020 FY | 14.34 Million USD | -12.78% |
| 2019 Q2 | 4.99 Million ILS | 25.38% |
| 2019 Q3 | 3.68 Million ILS | -26.17% |
| 2019 FY | 16.44 Million USD | -10.88% |
| 2019 Q4 | 3.79 Million USD | 2.93% |
| 2019 Q1 | 3.98 Million ILS | -19.19% |
| 2018 Q1 | 4.56 Million ILS | 1.2% |
| 2018 FY | 18.45 Million ILS | 5.2% |
| 2018 Q4 | 4.92 Million ILS | 15.96% |
| 2018 Q3 | 4.24 Million ILS | -10.0% |
| 2018 Q2 | 4.71 Million ILS | 3.44% |
| 2017 Q2 | 4.38 Million USD | 12.31% |
| 2017 Q3 | 4.74 Million USD | 8.05% |
| 2017 Q4 | 4.5 Million USD | -4.89% |
| 2017 FY | 17.54 Million ILS | 23.08% |
| 2017 Q1 | 3.9 Million USD | -13.33% |
| 2016 Q2 | 2.9 Million USD | 7.92% |
| 2016 Q3 | 4.15 Million USD | 43.14% |
| 2016 FY | 14.25 Million ILS | 10.05% |
| 2016 Q4 | 4.5 Million USD | 8.5% |
| 2016 Q1 | 2.68 Million USD | -25.55% |
| 2015 FY | 12.95 Million USD | 22.8% |
| 2015 Q4 | 3.61 Million USD | 16.86% |
| 2015 Q3 | 3.09 Million USD | -9.11% |
| 2015 Q2 | 3.4 Million USD | 19.46% |
| 2015 Q1 | 2.84 Million USD | -24.86% |
| 2014 Q2 | 2.2 Million USD | 18.52% |
| 2014 Q1 | 1.86 Million USD | 17.76% |
| 2014 FY | 10.54 Million USD | 79.94% |
| 2014 Q4 | 3.78 Million USD | 34.6% |
| 2014 Q3 | 2.81 Million USD | 27.49% |
| 2013 FY | 5.86 Million USD | 0.0% |
| 2013 Q2 | 1.49 Million USD | 25.79% |
| 2013 Q3 | 1.67 Million USD | 11.65% |
| 2013 Q4 | 1.58 Million USD | -5.29% |
| 2013 Q1 | 1.18 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|